Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are over 40 years old
- You have been diagnosed with Type 2 Diabetes (whether or not you use insulin) for at least 5 years
- You have been diagnosed with a heart or blood vessel disease (such as heart disease, stroke-related disease, or poor circulation in the legs) — OR — you have at least one of the following: diabetic eye disease, diabetic kidney disease, diabetic nerve damage, or elevated levels of a specific inflammation marker in your blood (hs-CRP), AND also have two or more of the following: high blood pressure for at least 6 months, high cholesterol, a body weight above a certain threshold (BMI ≥27 for men or ≥22 for women), or a history of smoking (confirm with trial site for exact details)
- You are willing to undergo evaluations using a device called HEMOTAG
- You are willing to attend standard medical check-up visits and have a specific blood test (NT-pro BNP) done
- You are willing to use the HEMOTAG device at home at least three days per week during certain 30-day periods throughout the study
- You are willing to send and receive the HEMOTAG kit by post at required times during the study
- You are able to give your informed consent to participate
Who may not be able to join:
- You have a serious illness where your life expectancy is less than 12 months
- You have a physical deformity or wound on your chest area that could prevent the HEMOTAG device from being applied properly
- You have a skin condition or sensitivity that could be made worse or cause significant discomfort by wearing skin electrodes
- You are currently enrolled in another interventional clinical trial (being part of an observational study or registry is acceptable)
- You are a prisoner or ward of the state
- You have a cognitive (thinking or memory) difficulty or other condition that may prevent you from fully following the study requirements, as judged by the study doctor
- You are not able to make a fully informed and voluntary decision to participate on your own (studies requiring a legal representative to provide consent are not eligible)
- You are not able to communicate in English
- You are pregnant or planning to become pregnant during the study
- You are a woman of childbearing potential who is unwilling or unable to use contraception during the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 954-399-3335
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the proportion of diabetic mellitus patients with cardiovascular events as identified by HEMOTAG measurements over a 12 month duration.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.